Ironwood Pharmaceuticals Balance Sheet
NASDAQ: IRWDHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ironwood Pharmaceuticals financial position
At the end of fiscal 2025, Ironwood Pharmaceuticals reported total assets of $396.9 million, up 13.1% from a year earlier against total liabilities of $658.7 million. Shareholders' equity was negative at -$261.8 million, meaning liabilities exceed assets; this is often the result of large share buybacks or accumulated losses. The company held $215.5 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 1.13, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Ironwood Pharmaceuticals balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 215.46M | 88.56M | 92.15M | 656.20M | 620.13M | 362.56M | 177.02M | 173.17M | 125.74M | 54.00M |
| Short-Term Investments | — | — | — | — | — | — | — | — | 95.68M | 251.21M |
| Receivables | 46.74M | 81.89M | 129.12M | 115.46M | 114.04M | 122.35M | 11.28M | 20.99M | 3.19M | 933.00K |
| Inventory | — | — | — | — | — | — | 648.00K | — | 735.00K | 1.08M |
| Total Current Assets | 274.18M | 182.37M | 233.29M | 780.63M | 745.23M | 495.84M | 306.85M | 266.44M | 311.60M | 380.18M |
| Property, Plant & Equipment | 3.41M | 4.50M | 5.58M | 6.29M | 7.58M | 8.93M | 12.43M | 7.65M | 17.27M | 20.51M |
| Goodwill | — | — | — | — | — | — | 785.00K | 785.00K | 785.00K | 785.00K |
| Intangible Assets | 2.04M | 2.86M | 3.68M | — | — | — | — | — | 159.91M | 166.12M |
| Total Assets | 396.90M | 350.91M | 471.07M | 1.10B | 1.13B | 559.24M | 402.75M | 332.05M | 605.67M | 709.82M |
| Accounts Payable | 2.90M | 2.13M | 7.83M | 483.00K | 935.00K | 661.00K | 3.98M | 14.89M | 15.96M | 17.70M |
| Total Current Liabilities | 242.22M | 38.85M | 276.10M | 25.52M | 161.70M | 32.17M | 40.93M | 119.52M | 66.03M | 91.13M |
| Long-Term Debt | — | 198.99M | 397.87M | 396.25M | 454.19M | 430.26M | — | 100.54M | 146.90M | 132.25M |
| Total Liabilities | 658.74M | 652.24M | 817.37M | 448.14M | 521.02M | 496.60M | 496.00M | 528.42M | 595.83M | 643.11M |
| Shareholders' Equity | -261.83M | -301.33M | -346.30M | 652.38M | 605.91M | 62.64M | -93.25M | -196.37M | 9.85M | 66.72M |
| Retained Earnings | -1.67B | -1.70B | -1.70B | -696.38M | -937.61M | -1.47B | -1.57B | -1.59B | -1.31B | -1.19B |
| Total Debt | — | 198.99M | 397.87M | 396.25M | 454.19M | 430.26M | — | 100.54M | 146.90M | 132.25M |
| Net Cash (Debt) | 215.46M | -110.43M | -305.71M | 259.95M | 165.94M | -67.69M | 177.02M | 72.64M | 74.52M | 172.97M |
| Shares Outstanding | 163.06M | 160.21M | 156.35M | 154.03M | 162.04M | 160.62M | 157.54M | 154.41M | — | — |
This table shows 10 annual periods of Ironwood Pharmaceuticals's balance sheet, from FY 2025 back to FY 2016, across 18 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow IRWD's reporting calendar. What is a balance sheet?